T. Rowe Price Associates’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-32,636
| Closed | -$734K | – | 2927 |
|
|
2022
Q4 | $734K | Sell |
32,636
-1,290
| -4% | -$29K | ﹤0.01% | 1945 |
|
|
2022
Q3 | $811K | Buy |
33,926
+971
| +3% | +$23.2K | ﹤0.01% | 1863 |
|
|
2022
Q2 | $959K | Sell |
32,955
-2,181
| -6% | -$63.5K | ﹤0.01% | 1914 |
|
|
2022
Q1 | $3.26M | Sell |
35,136
-24,186
| -41% | -$2.25M | ﹤0.01% | 1549 |
|
|
2021
Q4 | $5.65M | Buy |
59,322
+3,874
| +7% | +$369K | ﹤0.01% | 1481 |
|
|
2021
Q3 | $9.91M | Sell |
55,448
-285
| -0.5% | -$51K | ﹤0.01% | 1417 |
|
|
2021
Q2 | $16.4M | Sell |
55,733
-16,734
| -23% | -$4.93M | ﹤0.01% | 1345 |
|
|
2021
Q1 | $19.5M | Sell |
72,467
-13,636
| -16% | -$3.67M | ﹤0.01% | 1278 |
|
|
2020
Q4 | $19.9M | Buy |
86,103
+10,734
| +14% | +$2.48M | ﹤0.01% | 1227 |
|
|
2020
Q3 | $18.9M | Sell |
75,369
-3,521
| -4% | -$883K | ﹤0.01% | 1171 |
|
|
2020
Q2 | $21.3M | Buy |
+78,890
| New | +$21.3M | ﹤0.01% | 1127 |
|